Cargando…

Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis

INTRODUCTION: Involving patients in decision making adds value in the context of pharmacovigilance (PV). This added value goes beyond participation in spontaneous reporting systems for adverse drug reactions. However, there is a gap between allowing patients to report and actual patient involvement....

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hoof, Monica, Chinchilla, Katherine, Härmark, Linda, Matos, Cristiano, Inácio, Pedro, van Hunsel, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409619/ https://www.ncbi.nlm.nih.gov/pubmed/36008634 http://dx.doi.org/10.1007/s40264-022-01222-y

Ejemplares similares

Diabetes patient’s pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation
por: Matos, Cristiano, et al.
Publicado: (2020)

Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre
por: Habarugira, Jean Marie Vianney, et al.
Publicado: (2021)

COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes
por: Rolfes, Leàn, et al.
Publicado: (2022)

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb
por: Vrolijk, Misha F., et al.
Publicado: (2020)

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018)

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
por: Oosterhuis, Ingrid, et al.
Publicado: (2022)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approach
por: Sabblah, George Tsey, et al.
Publicado: (2022)

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre
por: Watson, Sarah, et al.
Publicado: (2017)

Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
por: Isah, Ambrose O., et al.
Publicado: (2023)

Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
por: DAVIDSON, Linda, et al.
Publicado: (2022)

What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects
por: van Eekeren, Rike, et al.
Publicado: (2018)

Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
por: Francescon, Sara, et al.
Publicado: (2016)

Veterinary pharmacovigilance in Europe: a survey of veterinary practitioners
por: De Briyne, Nancy, et al.
Publicado: (2017)

Conceptual framework for effective stakeholder engagement for pharmacovigilance in a resource limited setting
por: Adenuga, Babafunso A., et al.
Publicado: (2021)

A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022)

Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe
por: Brosch, Sabine, et al.
Publicado: (2019)

Stakeholders’ Perspective on the Integration of Pharmacovigilance Activities into the Eritrean Healthcare System: A Qualitative Study
por: Abraham, Natnael Araya, et al.
Publicado: (2023)

Linked health data for pharmacovigilance in children: perceived legal and ethical issues for stakeholders and data guardians
por: Hopf, Yvonne Marina, et al.
Publicado: (2014)

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
por: Sartori, Daniele, et al.
Publicado: (2022)

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
por: Smeets, Tim, et al.
Publicado: (2016)

Curling of Hair in Two Female Patients Taking Alitretinoin
por: Alting, Kim, et al.
Publicado: (2018)

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

Stakeholder bias in best practice advisories: an ethical perspective
por: Baird, Aaron, et al.
Publicado: (2020)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
por: Sartori, Daniele, et al.
Publicado: (2020)

Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis
por: Tiemersma, Everdina W., et al.
Publicado: (2021)

Financial losses for Dutch stakeholders during the 2013 aflatoxin incident in Maize in Europe
por: Focker, M., et al.
Publicado: (2021)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Gathering and Exploring Scientific Knowledge in Pharmacovigilance
por: Lopes, Pedro, et al.
Publicado: (2013)

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study
por: Härmark, Linda, et al.
Publicado: (2012)

Unbearable Pruritus After Withdrawal of (Levo)cetirizine
por: Ekhart, Corine, et al.
Publicado: (2016)

Engaging community stakeholders in research on best practices for clinical genomic sequencing
por: Griesemer, Ida, et al.
Publicado: (2020)

Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product
por: van Hunsel, Florence, et al.
Publicado: (2015)

Dictionary of pharmacovigilance /
por: Alghabban, Amer
Publicado: (2004)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Challenges in pharmacovigilance
por: Dikshit, R. K.
Publicado: (2010)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ehmotd2p636a979nnsmu8ujedr